Cleared Traditional

K061088 - SENTRY OTC MONITOR

K061088 is the FDA 510(k) clearance for SENTRY OTC MONITOR by Honeywell Hommed, LLC. It is a Class 2 Cardiovascular device (product code DRG) cleared through the Traditional 510(k) pathway after a 52-day FDA review.

K061088 · Honeywell Hommed, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2006
Decision
52d
Days
Class 2
Risk

K061088 is an FDA 510(k) clearance for the SENTRY OTC MONITOR. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Honeywell Hommed, LLC (Houston, US). The FDA issued a Cleared decision on June 9, 2006 after a review of 52 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Honeywell Hommed, LLC devices

Submission Details

510(k) Number K061088 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 18, 2006
Decision Date June 09, 2006
Days to Decision 52 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
73d faster than avg
Panel avg: 125d · This submission: 52d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 72
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K061088.
FORA TELEHEALTH SYSTEM
K083046 · Taidoc Technology Corporation · Jan 2009
MOTIVA MONITOR DEVICE CONNECTIVITY, MODEL# 453564036921
K071564 · Philips Medical Systems · Aug 2007
MULTIPLE PATIENT RECEIVER, MODEL ORG-9700A
K071058 · Nihon Kohden America, Inc. · Jun 2007
THE PHILIPS MP20, MP30, MP40, MP50, MP60, MP70, AND MP90 INTELLIVUE PATIENT MONITORS, WITH 802.11 WIRELESS LAN
K052961 · Philips Medical Systems · Nov 2005
THE M3810A PHILIPS TELEMONITORING SYSTEM WITH M3812B TELESTATION (M310A/12B)
K023749 · Philips Medical Systems · Nov 2002
MODIFICATION OF: PHYSIOLOGICAL SIGNAL TRANSMITTER AND RECEIVER, MODEL 3810A
K993169 · Hewlett-Packard Co. · Dec 1999